Nanosonics (ASX:NAN) Net Margin % : 7.75% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Nanosonics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Nanosonics's Net Income for the six months ended in Dec. 2023 was A$6.2 Mil. Nanosonics's Revenue for the six months ended in Dec. 2023 was A$79.6 Mil. Therefore, Nanosonics's net margin for the quarter that ended in Dec. 2023 was 7.75%.

The historical rank and industry rank for Nanosonics's Net Margin % or its related term are showing as below:

ASX:NAN' s Net Margin % Range Over the Past 10 Years
Min: -24.58 Med: 8.95 Max: 38.75
Current: 9.47

ASX:NAN's Net Margin % is ranked better than
72.41% of 819 companies
in the Medical Devices & Instruments industry
Industry Median: -0.85 vs ASX:NAN: 9.47

Nanosonics Net Margin % Historical Data

The historical data trend for Nanosonics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Net Margin % Chart

Nanosonics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Margin %

Get a 7-Day Free Trial

16.08

10.06

8.42

3.13

11.87

Nanosonics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial															6.53	-0.22	12.71	11.07	7.75

Competitive Comparison of Nanosonics's Net Margin %

For the Medical Instruments & Supplies subindustry, Nanosonics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanosonics's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanosonics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Nanosonics's Net Margin % falls into.

Nanosonics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Nanosonics's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	19.883	/	167.515
	=	11.87 %

Nanosonics's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	6.168	/	79.638
	=	7.75 %

Nanosonics (ASX:NAN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Nanosonics Net Margin % Related Terms

Thank you for viewing the detailed overview of Nanosonics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosonics (ASX:NAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (ASX:NAN) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

NNCSF:USA OQS:Germany

Address

7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113

Website

https://www.nanosonics.com.au

Nanosonics is a single-product firm and its trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At June 2022, there were 29,850 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in Asia-Pacific.